169 related articles for article (PubMed ID: 31897135)
1. Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy.
Jeong JU; Jeon W; Ahn SJ; Kim YC; Oh IJ; Park CK; Yoon MS; Song JY; Nam TK; Chung WK
Oncol Lett; 2020 Jan; 19(1):239-246. PubMed ID: 31897135
[TBL] [Abstract][Full Text] [Related]
2. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
3. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
[TBL] [Abstract][Full Text] [Related]
4. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.
Luan Z; Wang Z; Huang W; Zhang J; Dong W; Zhang W; Li B; Zhou T; Li H; Zhang Z; Wang Z; Sun H; Yi Y
Exp Ther Med; 2015 Aug; 10(2):671-678. PubMed ID: 26622373
[TBL] [Abstract][Full Text] [Related]
6. Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.
Zahra A; Chang T; Hejleh TA; Furqan M; Clamon GH; Bhatia SK; Watkins JM; Mott SL; Ahmann LL; Bodeker KL; Spitz DR; Buatti JM; Allen BG
J Oncol Transl Res; 2016 Nov; 2(1):. PubMed ID: 27981260
[TBL] [Abstract][Full Text] [Related]
7. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Etoposide/Cisplatin Combination Chemotherapy (EP) and Thoracic Radiotherapy after Two Cycles of EP for Limited Stage Small Cell Lung Cancer.
Sohn HJ; Kim SW; Ahn JH; Kang HJ; Park S; Jung HN; Suh CW; Kim WK; Lee SW; Choi EK; Lee SD; Kim WS; Kim DS; Kim WD; Lee JS
Cancer Res Treat; 2002 Dec; 34(6):409-15. PubMed ID: 26680896
[TBL] [Abstract][Full Text] [Related]
10. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
[TBL] [Abstract][Full Text] [Related]
11. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
[TBL] [Abstract][Full Text] [Related]
14. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
[TBL] [Abstract][Full Text] [Related]
15. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
16. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
Sas-Korczynska B; Sokolowski A; Korzeniowski S
Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
[TBL] [Abstract][Full Text] [Related]
17. Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.
Zhu L; Zhang S; Xu X; Wang B; Wu K; Deng Q; Xia B; Ma S
PLoS One; 2016; 11(5):e0156494. PubMed ID: 27227819
[TBL] [Abstract][Full Text] [Related]
18. Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
Barros JM; Rizzo MM; Chiozza JO; Couñago F
World J Clin Oncol; 2021 Jan; 12(1):1-5. PubMed ID: 33552934
[TBL] [Abstract][Full Text] [Related]
19. Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
Wang P; Liu W; Zhao L; Wang P
Thorac Cancer; 2015 Sep; 6(5):605-12. PubMed ID: 26445609
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
